Published in Cas Lek Cesk on September 24, 1981
The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma. Neoplasma (1968) 0.90
Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour. Neoplasma (1969) 0.83
Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Neoplasma (1972) 0.80
Effect of combined chemotherapy tested in partially hepatectomized rats bearing Zajdela hepatoma. Neoplasma (1983) 0.75
Comparison of the effectivity of two diaminocyclohexane Pt-complexes. Neoplasma (1985) 0.75
Chromosomal studies with the nitrogen mustard-sensitive and resistant Yoshida tumour. Neoplasma (1968) 0.75
The value of the short term predictive assay in the inductive treatment of patients with acute nonlymphoblastic leukemia. Neoplasma (1986) 0.75
Stabilization of a DNA-Histone complex after nitrogen mustard action in vitro. Neoplasma (1969) 0.75
Experimental antibodies to Walker ascitic tumor cell nuclei: their production and biological activity. Experientia (1968) 0.75
Heterogeneity of tumor cells. Antibiot Chemother (1971) (1980) 0.75
Stimulation of rat liver regeneration by chloramphenicol. Neoplasma (1975) 0.75
Attempt to increase the effect of regional chemotherapy in experimental tumours by procaine. Neoplasma (1969) 0.75
Accelerated appearance of an ascitic tumour after long-term application of interferon to NZB/W mice. Acta Virol (1981) 0.75
Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP). Neoplasma (1990) 0.75
Mitochondrial adenosine triphosphatase of Zajdela hepatoma. III. Effect of uncouplers on the hydrolysis of intramitochondrial ATP. Neoplasma (1977) 0.75
Blastic crisis of chronic myelogenous leukaemia. Neoplasma (1969) 0.75
Mitochondrial ATPase of Zajdela hepatoma. Presence of F1-specific antigenic determinants outside mitochondria. FEBS Lett (1978) 0.75
Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells. Neoplasma (1972) 0.75
[Mixed, Yoshida-type tumors, resistant and sensitive to alkylating agents]. Cas Lek Cesk (1966) 0.75
The degree and stability of resistance of a nitrogen mustard-resistant subline of Yoshida tumour. Folia Biol (Praha) (1965) 0.75
Alteration of SRBC immunogenicity by cytostatics (Ypenyl and Cytembena). Neoplasma (1973) 0.75
Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates. Int J Cancer (1991) 0.75
Resistance of amino acid incorporation by mitochondria isolated from Ehrlich ascites tumour cells to the in vivo treatment with 5-fluorouracil. Neoplasma (1972) 0.75
[Some properties of the new antimetabolite--3-oxauracil (author's transl)]. Bratisl Lek Listy (1978) 0.75
Immunosuppression with Cytembena: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Neoplasma (1973) 0.75
Comparison of some biochemical parameters of arabinosylcytosine and cyclocytidine in L1210 murine leukemia cells. Neoplasma (1990) 0.75
Biotransformation and in vitro activity of an arabinosylcytosine 5'-chloro-5'-deoxy analog. Anticancer Drugs (1991) 0.75
Inhibition of colony-forming cells from bone marrow of leukemic patients by 3-oxauracil. Neoplasma (1981) 0.75
Proliferation rate--drug sensitivity relation in clones isolated from heterogeneic tumor cell population. Neoplasma (1980) 0.75
Drug resistance induction and cross-resistance studies with Pt-complexes. Neoplasma (1984) 0.75
The disposition of new arabinosylcytosine derivative-- 5'-chloro-5'-deoxy-arabinosylcytosine--in rats. Gen Pharmacol (1995) 0.75
Combined chemoimmunotherapy of L5178Y lymphoma. Neoplasma (1978) 0.75
Effect of "3-oxauracil" (2,3-dihydro-1,3-6H-oxazine-dione) in L1210 leukemia. Neoplasma (1977) 0.75
Cytoplasmic inheritance in metazoa and its relationship to cell phenotype. 3. Uptake of mouse liver cell fractions by 6C3HED lymphosarcoma cells in vitro. Neoplasma (1970) 0.75
[The development and contribution of experimental oncology to clinical practice]. Cas Lek Cesk (1988) 0.75
Mitochondrial ATPase of Zajdela hepatoma. II. Mitochondria of Zajdela hepatoma contain less adenosine triphosphatase than mitochondria of rat liver. Neoplasma (1977) 0.75
Preliminary report. Antigenicity of the mice Ehrlich ascitic tumor cell nuclei. Neoplasma (1969) 0.75
ADP, ATP translocator protein of rat heart, liver and hepatoma mitochondria exhibits immunological cross-reactivity. FEBS Lett (1978) 0.75
The effect of 5-fluorouracil, ethidium bromide and chloramphenicol on some mitochondrial functions in regenerating rat liver. Neoplasma (1974) 0.75
[Trends in oncologic research]. Cas Lek Cesk (1986) 0.75
Antitumor activity and cross-resistance studies with Pt-ascorbato complexes. Neoplasma (1989) 0.75
Effect of alkylating agents on hormone induction of rat liver tryptophan pyrrolase. Neoplasma (1968) 0.75
Some properties of coupled hepatoma mitochondria exhibiting uncoupler-insensitive ATPase activity. Biochem Biophys Res Commun (1973) 0.75
Different inhibitory effect of nitrogen mustard (HN2) and TS-160 (HN3) on choline transport in L 5178Y lymphoblasts. Neoplasma (1975) 0.75
Single versus combination chemotherapy of L1210 leukemia. Neoplasma (1980) 0.75
[The prognosis for cancer research and the campaign against cancer in countries belonging to the Council for Mutual Economic Assistance to the year 2000]. Cas Lek Cesk (1982) 0.75
Mannitol-busulphan in advanced ovary carcinoma. Neoplasma (1966) 0.75
[Cytostatic effects of L-asparaginase on models of sensitive and resistant tumors]. Bratisl Lek Listy (1971) 0.75
[Kinetics of neoplastic cells and chemotherapy]. Cas Lek Cesk (1972) 0.75
Mitochondrial ATPase of Zajdela hepatoma. V. Mitochondria of Zajdela hepatoma contain membrane sectors of ATPase complex unassociated with F1. Neoplasma (1978) 0.75
In vivo and in vitro effectivity of some platinum complexes. Neoplasma (1984) 0.75
Formation, size, and solubility in chloroform/methanol of products of protein synthesis in isolated mitochondria of rat liver and Zajdela hepatoma. Eur J Biochem (1975) 0.75
Effect of arabinosylcytosine derivative cyclocytidine on hepatal functions in rats and on Zajdela hepatoma. Gen Pharmacol (1994) 0.75
Clinical application of myelobromol in chronic myeloses. Neoplasma (1966) 0.75
Clastogenicity and sister chromatid exchange induction by ftorafur. Neoplasma (1981) 0.75
Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems. Neoplasma (1986) 0.75
Unequal inhibition of RNA synthesis in mitochondria and whole cells of Ehrlich ascites tumour treated with 5-fluorouracil. Neoplasma (1972) 0.75
In vitro passages of hamster tumour cells induced with Schmidt-Ruppin strain of Rous sarcoma viruse: their oncogenicity, morphology and karyology. Neoplasma (1968) 0.75